Immunohistochemical expression of p53, MDM2, and p21Waf1 oncoproteins in endometriomas but not adenomyosis

Journal of the Society for Gynecologic Investigation

Volumn 12, Issue 4, 2005, Pages 263-266

  Goumenou, Anastasia ^b   Panayiotides, Ioannis ^b   Mahutte, Neal G ^a   Matalliotakis, Ioannis ^b   Fragouli, Yvoni ^b   Arici, Aydin ^b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

Adenomyosis; Endometriosis; Immunohistochemistry; Oncoprotein

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; ONCOPROTEIN; PROTEIN MDM2; PROTEIN P53;

ADENOMYOSIS; ADULT; ARTICLE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; ENDOMETRIUM TUMOR; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; TISSUE SECTION;

ADULT; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ENDOMETRIOSIS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 18144366956     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsgi.2005.01.028     Document Type: Article

References (27)

1. T. Harada, A. Kaponis, T. Iwabe Apoptosis in human endometrium and endometriosis Hum Reprod Update 10 2004 29 38
2. J. Garcia-Velasco, A. Arici Apoptosis and the pathogenesis of endometriosis Semin Reprod Med 21 2003 165 172
3. C.A. Witz Pathogenesis of endometriosis Gynecol Obstet Invest 53 2002 52 62
4. E. Seli, M. Berkkanoglu, A. Arici Pathogenesis of endometriosis Obstet Gynecol Clin North Am 30 2003 41 61
5. A. Arici, I. Matalliotakis, A. Goumenou, G. Koumantakis, S. Vassiliadis, N.G. Mahutte Altered expression of interleukin-18 in the peritoneal fluid of women with endometriosis Fertil Steril 80 2003 889 894
6. E. Koumantakis, I. Matalliotakis, M. Neonaki, G. Froudarakis, V. Georgoulias Soluble serum interleukin-2 receptor, interleukin-6 and interleukin-1a in patients with endometriosis and in controls Arch Gynecol Obstet 255 1994 107 112
7. B. Vogelstein, K.W. Kinzler p53 function and dysfunction Cell 70 1992 523 526
8. K. Roemer, T. Friedmann Mechanisms of action of the p53 tumor suppressor and prospects for cancer gene therapy by reconstitution of p53 function Ann NY Acad Sci 716 1994 265 280
9. C. Cadwell, G.P. Zambetti The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth Gene 277 2001 15 30
10. F. Chang, S. Syrjanen, K. Syrjanen Implications of the p53 tumor-suppressor gene in clinical oncology J Clin Oncol 13 1995 1009 1022
11. X. Wu, J.H. Bayle, D. Olson, A.J. Levine The p53-mdm-2 autoregulatory feedback loop Genes Dev 7 1993 1126 1132
12. Y. Haupt, R. Maya, A. Kazaz, M. Oren MDM2 promotes the rapid degradation of p53 Nature 387 1997 296 299
13. D.A. Freedman, L. Wu, A.J. Levine Functions of the MDM2 oncoprotein Cell Mol Life Sci 55 1999 96 107
14. W.S. El-Deiry, T. Tokino, V.E. Velculescu WAF1, a potential mediator of p53 tumor suppression Cell 75 1993 817 825
15. W.S. El-Deiry, J.W. Harper, P.M. O'connor WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis Cancer Res 54 1994 1169 1174
16. K.E. Valassiadou, K. Stefanaki, M. Tzardi Immunohistochemical expression of p53, bcl-2, MDM2 and waf1/p21 proteins in colorectal adenocarcinomas Anticancer Res 17 1997 2571 2576
17. J. Plisiecka-Halasa, G. Karpinska, T. Szymanska P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens Ann Oncol 14 2003 1078 1085
18. K. Milde-Langosch, M. Hagen, Am Bamberger, T. Loning Expression and prognostic value of the cell-cycle regulatory proteins, Rb, p16MTS1, p21WAF1, p27KIP1, cyclin E, and cyclin D2, in ovarian cancer Int J Gynecol Pathol 22 2003 168 174
19. G. Ferrandina, A. Stoler, A. Fagotti p21WAF1/CIP1 protein expression in primary ovarian cancer Int J Oncol 17 2000 1231 1235
20. M. Taskin, T.A. Lallas, M. Shevchuk, H.R. Barber P53 expression in adenomyosis in endometrial carcinoma patients Gynecol Oncol 62 1996 241 246
21. Revised American Fertility Society classification of endometriosis: 1985 Fertil Steril 43 1985 351 352
22. J.J. Molitor Adenomyosis A clinical and pathological appraisal Am J Obstet Gynecol 110 1971 275 284
23. M. Harada, N. Suganuma, M. Furuhashi Detection of apoptosis in human endometriotic tissues Mol Hum Reprod 2 1996 307 315
24. E. Giannikaki, C. Kouvidou, M. Tzardi p53 protein expression in breast carcinomas. Comparative study with the wild type p53 induced proteins MDM2 and p21/waf1 Anticancer Res 17 1997 2123 2127
25. R.A. Steinman, B. Hoffman, A. Iro, C. Guillouf, D.A. Liebermann, M.E. el-Housei Induction of p21 (WAF-1/CIP1) during differentiation Oncogene 9 1994 3389 3396
26. Z. Zhang, H. Wang, M. Li, S. Agrawal, X. Chen, R. Zhang MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53 J Biol Chem 279 2004 16000 16006
27. F.Z. Bischoff, M. Heard, J.L. Simpson Somatic DNA alterations in endometriosis High frequency of chromosome 17 and p53 loss in late-stage endometriosis J Reprod Immunol 55 2002 49 64